Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Atricure Inc (ATRC)

Atricure Inc (ATRC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,426,008
  • Shares Outstanding, K 45,882
  • Annual Sales, $ 206,530 K
  • Annual Income, $ -48,160 K
  • 60-Month Beta 1.04
  • Price/Sales 16.30
  • Price/Cash Flow N/A
  • Price/Book 9.05
Trade ATRC with:

Options Overview Details

View History
  • Implied Volatility 41.34%
  • Historical Volatility 29.77%
  • IV Percentile 11%
  • IV Rank 19.67%
  • IV High 79.63% on 10/23/20
  • IV Low 31.97% on 08/06/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 35

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.28
  • Number of Estimates 2
  • High Estimate -0.22
  • Low Estimate -0.33
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -154.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.00 +3.26%
on 08/27/21
77.66 -4.26%
on 09/09/21
-0.94 (-1.25%)
since 08/23/21
3-Month
69.91 +6.35%
on 08/11/21
85.50 -13.04%
on 08/05/21
-3.10 (-4.00%)
since 06/23/21
52-Week
34.04 +118.42%
on 10/30/20
85.50 -13.04%
on 08/05/21
+35.83 (+93.02%)
since 09/23/20

Most Recent Stories

More News
AtriCure to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating...

MS : 103.55 (+2.73%)
ATRC : 74.35 (-0.43%)
AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of -9.09% and 15.91%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

ATRC : 74.35 (-0.43%)
AtriCure Reports Second Quarter 2021 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced second quarter 2021 financial results.

ATRC : 74.35 (-0.43%)
AtriCure to Participate at the Canaccord 41st Annual Growth Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating...

ATRC : 74.35 (-0.43%)
Mycoplasma Testing Global Market Report 2021: COVID-19 Growth And Change

Reportlinker.com announces the release of the report "Mycoplasma Testing Global Market Report 2021: COVID-19 Growth And Change" - https://www.reportlinker.com/p06103730/?utm_source=GNW

ATRC : 74.35 (-0.43%)
CRL : 455.04 (+1.95%)
CNMD : 130.92 (+1.01%)
MKKGY : 46.5700 (+0.91%)
OCPNY : 21.3950 (+0.05%)
SNN : 36.90 (+1.60%)
AtriCure to Announce Second Quarter 2021 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release second quarter 2021 financial...

ATRC : 74.35 (-0.43%)
AtriCure Names Two New Members to the Board of Directors

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that Deborah H. Telman and Maggie Yuen have been...

ATRC : 74.35 (-0.43%)
OGN : 33.38 (+2.24%)
MRK : 73.05 (+1.40%)
SRNE : 8.08 (+1.13%)
JCI : 74.08 (+1.73%)
ABT : 125.30 (+0.52%)
BA : 221.10 (+1.90%)
PEN : 282.59 (-1.36%)
TMO : 608.23 (+0.26%)
BSX : 45.00 (+1.56%)
AtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock?

AtriCure (ATRC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in...

ATRC : 74.35 (-0.43%)
AtriCure's EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients

--Superiority trial showed a 29% difference in effectiveness at 12 months and a 35% difference in effectiveness at 18 months for long-standing persistent Afib patients.

ATRC : 74.35 (-0.43%)
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of 7.32% and 5.39%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

ATRC : 74.35 (-0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

3rd Resistance Point 76.28
2nd Resistance Point 75.79
1st Resistance Point 75.07
Last Price 74.35
1st Support Level 73.86
2nd Support Level 73.37
3rd Support Level 72.65

See More

52-Week High 85.50
Last Price 74.35
Fibonacci 61.8% 65.84
Fibonacci 50% 59.77
Fibonacci 38.2% 53.70
52-Week Low 34.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar